Synthetic isoxazole as antiplatelet agent

Author： Gutiérrez Margarita   Amigo Jessica   Fuentes Eduardo   Palomo Ivan   Astudillo Luis  

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.25, Iss.4, 2014-06, pp. : 234-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

In the Bivalirudin Era, Are We Still Looking for a Potent Antiplatelet Agent?

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-07 ,pp. : 476-478

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Synthetic Anti-Acute Pancreatitis Agent, IS-741

By  

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 34-39

Karger

Access to resources Recommend Favorite

Modulation of Vasoconstriction by Clopidogrel and Ticlopidine - A new safe and effective antiplatelet agent. But unanswered questions remain

By Yang L.H.   Hoppensteadt D.   Fareed J.  

Thrombosis Research, Vol. 92, Iss. 2, 1998-10 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

Effects of the Antiplatelet Agent TA-993 and Its Metabolite MB3 on the Hemorheological Properties of Rat and Human Erythrocytes

By Katoh M.   Karasawa T.   Doi H.   Odawara A.  

Thrombosis Research, Vol. 104, Iss. 2, 2001-10 ,pp. : 105-112

Elsevier

Access to resources Recommend Favorite

Edaravone (Radical Scavenger) versus Sodium Ozagrel (Antiplatelet Agent) in Acute Noncardioembolic Ischemic Stroke (EDO Trial)

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-03 ,pp. : 485-492

Karger

Access to resources Recommend Favorite